MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-07-2024
BIOLASE Shares 2011-2026 | BIOL
Annual Shares BIOLASE
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.28 M | 69 K | 59 K | 2.44 M | 23.2 M | 20.6 M | 14.8 M | 12.9 M | 12.4 M | 9 M | 6.98 M | 6.84 M | 6.49 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 23.2 M | 59 K | 9 M |
Quarterly Shares BIOLASE
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36.1 M | 33.4 M | 17.8 M | 3.42 M | 1.18 M | 545 K | 328 K | 77 K | 76 K | 61 K | 6.16 M | 6.15 M | 6.08 M | 6.03 M | 135 M | 97.7 M | 81.3 M | 38 M | 31.5 M | 31.4 M | 21.9 M | 21.6 M | 21.1 M | 22 M | 20.6 M | 20.5 M | 20.5 M | 20.5 M | 15.2 M | 13.6 M | 67.6 M | 67.6 M | 58.6 M | 58.3 M | 58.2 M | 58.2 M | 58.2 M | 58.2 M | 58.1 M | 37.4 M | 42.4 M | 37.6 M | 36.5 M | 37.4 M | 32.7 M | 32.4 M | 32.2 M | 31.3 M | 31.9 M | 31.7 M | 31.4 M | 30.5 M | 31 M | 29 M | 27.3 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 135 M | 61 K | 32.8 M |
Shares of other stocks in the Medical devices industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apollo Endosurgery
APEN
|
40.7 M | - | - | $ 475 M |  USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
67.5 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
46.7 M | - | - | $ 3.31 B | USA |
 |
Acutus Medical
AFIB
|
29.1 M | - | -26.83 % | $ 2.62 M | USA |
 |
Lianluo Smart Limited
LLIT
|
17.8 M | - | 24.59 % | $ 44.8 M |  China |
 |
Cognyte Software Ltd.
CGNT
|
71.8 M | $ 7.22 | - | $ 518 M |  Israel |
 |
Obalon Therapeutics, Inc.
OBLN
|
7.77 M | - | -5.86 % | $ 30.6 M | USA |
 |
Aziyo Biologics
AZYO
|
18.2 M | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
34.6 M | $ 3.91 | -1.69 % | $ 135 M | USA |
 |
Alphatec Holdings
ATEC
|
143 M | $ 13.54 | -2.59 % | $ 1.94 B | USA |
 |
Conformis
CFMS
|
7.22 M | - | - | $ 16.4 M | USA |
 |
Bio-Rad Laboratories
BIO
|
28.2 M | $ 294.76 | -1.65 % | $ 8.32 B | USA |
 |
Bruker Corporation
BRKR
|
149 | - | 1.76 % | $ 6.31 K | USA |
 |
BioSig Technologies
BSGM
|
14 M | - | 37.08 % | $ 85.7 M | USA |
 |
CONMED Corporation
CNMD
|
30.8 M | $ 42.22 | -1.31 % | $ 1.3 B | USA |
 |
Boston Scientific Corporation
BSX
|
1.47 B | - | -0.69 % | $ 108 B | USA |
 |
Abbott Laboratories
ABT
|
1.74 B | - | 0.72 % | $ 197 B | USA |
 |
Cutera
CUTR
|
19.9 M | - | -10.19 % | $ 1.99 M | USA |
 |
Cardiovascular Systems
CSII
|
39.2 M | - | 0.15 % | $ 844 M | USA |
 |
CryoLife, Inc.
CRY
|
37.9 M | - | -4.14 % | $ 702 M | USA |
 |
ClearPoint Neuro
CLPT
|
27 M | $ 13.28 | -2.28 % | $ 359 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
81.1 K | - | 1.15 % | $ 34.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
37.3 M | $ 5.0 | 8.7 % | $ 186 M |  France |
 |
Dynatronics Corporation
DYNT
|
8.13 M | - | 14.99 % | $ 929 K | USA |
 |
Soliton, Inc.
SOLY
|
21.1 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
859 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
13.8 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
14.7 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
63 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
32.7 M | - | - | $ 955 M | USA |
 |
InMode Ltd.
INMD
|
79.3 M | $ 14.26 | -2.67 % | $ 1.13 B | Israel |
 |
Eargo
EAR
|
3.97 M | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
8.45 M | - | - | $ 207 M | USA |
 |
Second Sight Medical Products
EYES
|
55 K | - | -0.97 % | $ 54.4 M | USA |
 |
Avinger
AVGR
|
786 K | - | -20.74 % | $ 369 K | USA |
 |
FONAR Corporation
FONR
|
6.55 M | $ 18.57 | -0.75 % | $ 122 M | USA |
 |
IRadimed Corporation
IRMD
|
12.7 M | $ 103.26 | - | $ 1.31 B | USA |
 |
GBS
GBS
|
5.27 M | - | -0.57 % | $ 7.12 M | USA |
 |
Integer Holdings Corporation
ITGR
|
33.6 M | $ 86.35 | - | $ 2.9 B | USA |
 |
Globus Medical
GMED
|
136 M | $ 88.28 | -0.37 % | $ 12 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
77 M | $ 11.05 | - | $ 851 M | USA |
 |
Pulmonx Corporation
LUNG
|
39.1 M | $ 1.45 | -0.34 % | $ 56.7 M | USA |
 |
Establishment Labs Holdings
ESTA
|
28.2 M | $ 72.06 | - | $ 2.03 B |  Costa-rica |
 |
Medigus Ltd.
MDGS
|
78.1 M | - | 10.28 % | $ 55.5 M | Israel |
 |
IRIDEX Corporation
IRIX
|
16.1 M | $ 1.43 | - | $ 23.1 M | USA |
 |
Invacare Corporation
IVC
|
36.5 M | - | - | $ 24.7 M | USA |
 |
Cytosorbents Corporation
CTSO
|
54.4 M | $ 0.62 | -7.09 % | $ 33.7 M | USA |
 |
Profound Medical Corp.
PROF
|
20.5 M | - | 0.16 % | $ 180 M | Canada |